|
Mini-Reviews
in Medicinal Chemistry
ISSN: 1389-5575 - Volume 8, 14 Issues, 2008

Co-Editors-In-Chief:
A. Paul Krapcho
The University of Vermont
Department of Chemistry
Cook Physical Science Building
Burlington,Vermont,USA
Tel: +1-802-656-0271
Fax: +1-802-656-8705
Email: A.Paul.Krapcho@uvm.edu
Patrice Talaga
Associate Director, Discovery Technologies
Global Chemistry, R&D
UCB S.A., Chemin du Foriest
B-1420 Braine-l'Alleud, Belgium
Tel: +32-23862727
Fax: +32-23862704
E-mail: Patrice.Talaga@UCB-Group.com
Atta-ur-Rahman, FRS
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270, Pakistan
Tel: +92-21-4824924
Fax:+92-21-4975781, 4977491, 4819018-19
E-mail: mhej@cyber.net.pk
M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270, Pakistan
Tel: +92-21-4824924
Fax:+92-21-4819018-19
E-mail: hej@cyber.net.pk
Regional Editors:
Daniela Barlocco (Ist. Chim. Farm. Toss.,
Milano, Italy)
Masereel Bernard (University of Namur, Namur, Belgium)
Gildas Bertho (Université René Descartes
Paris, Paris, France)
Peter Chiba (Universität Wien, Vienna, Austria)
Paola Conti (Istituto di Chimica Farmaceutica Milano,
Italy)
Maria Paola Costi (Universitá degli Studi di
Modena, Modena, Italy)
Alain Gueiffier (Universite Tours, Tours, France)
S.M. Husbands (University of Bath, Bath, UK)
Reuben Jih-Ru Hwu (Tsing Hua University, Hsinchu, Taiwan)
Huba Kalasz (Semmelweis University, Budapest, Hungary)
Yoshiyuki Kawakami (Eisai Co., Ltd., Ibaraki, Japan)
Maria Luz Lopez-Rodriguez (University of Madrid, Madrid,
Spain)
Antonello Mai (Universita degli Studi di Roma, "La
Sapienza", Roma, Italy)
Ana Martinez (Neuropharma, Madrid, Spain)
Raimund Mannhold (Heinrich-Heine-Universitat, Dusseldorf,
Germany)
Chris Meier (Universitaet Hamburg, Hamburg, Germany)
Ramaiah Muthyala (University of Minnesota,
Minneapolis, MN, USA)
Frederic Ooms (Euroscreen S.A., Gosselies, Belgium)
Teruyuki Sakai (Kirin Brewery Co., Ltd., Gunma, Japan)
Shalom Sarel (The Hebrew University of Jerusalem, Jerusalem,
Israel)
K.R. Scott (Howard University, Washington, DC, USA)
Hisashi Shinkai (JT Inc., Osaka, Japan)
Mark A. Smith (Case Western Reserve University,
Cleveland, OH, USA)
Masaaki Suzuki (Molecular Imaging Research
Program (MIRP), RIKEN, Kobe, Japan)
Nikos Tagmatarchis (Theoretical and Physical Chemistry
Institute, Athens, Greece)
Karl Werbovetz (The Ohio State University, Columbus,
OH, USA)
Ross Mcgeary (The University of Queensland, Brisbane,
Australia)
Boulos Zacharie (Prometic Biosciences Inc, Laval QC
H7V 5B7, Canada)
Editorial Advisory Board:
Andrew Abell (The University of Adelaide,
Adelaide, Australia)
Syed M. Ali (ArQule Inc., Woburn, MA, USA)
K.H. Altmann (Novartis Pharma AG, Basel, Switzerland)
Rathindra Bose (Northern Illinois University, DeKalb,
IL, USA)
Hugo Cerecetto (Dep. Quimica Organica, Montevideo,
Uruguay)
Ji-wang Chern (National Taiwan University, Taipei,
Taiwan)
Erik de Clerq (Katholieke Universiteit Leuven, Leuven,
Belgium)
Asim K. Debnath (Lindsley F. Kimball Research Institute,
NY, USA)
Albena Todorova Dinkova-Kostova (Johns Hopkins University,
MD, USA)
Jean-Michel Dogné (University of Liége,
Liége, Belgium)
Yuxiang Dong (University of Nebraska Medical Center,
Omaha, NE, USA)
Solo Goldstein (Institut de Recherches Servier, Suresnes,
France)
Margaret M. Harding (University of Sydney, Sydney,
Australia)
Andreas Hilgeroth (Martin-Luther-University, Halle,
Germany)
Terry C. Jenkins (University of Bradford, Bradford,
UK)
Tomas Girbes (Universidad de Valladolid, Vallodolid,
Spain)
Mankil Jung (Yonsei University, Seoul, Korea)
Dirk C.M. Leysen (Organon, Oss. The Netherlands)
Jean-Françios Liegeois (University of Liege,
Liege, Belgium)
Ana Martinez (Instituto de Quimica Medica-CSIC,
Madrid, Spain)
Ian A. McDonald (Pharmaxis Ltd., Frenchs Forest, Australia)
S. Mehta (Ambit Biosciences, San Diego CA, USA)
Martin Missbach (Novartis Pharma AG, Basel, Switzerland)
Guillermo A. Morales (Semafore Pharmaceuticals Inc.,
Indianapolis, IN, USA)
P. Moreira (University of Coimbra, Coimbra,
Portugal)
Christa E. Mueller (Universitaet Bonn, Bonn, Germany)
Sunil Nagpal (Eli Lilly and Company, Indianapolis,
IN, USA)
Ion Niculescu-Duvaz (Centre for Cancer Therapeutics,
Surrey, UK)
Hideaki NATSUGARI (Teikyo University, Kanagawa,
Japan)
G. Perry (University of Texas at San Antonio,
Texas 78249-0661, USA)
Georg Petroianu (der Universitaet Heidelberg, Mannheim,
Germany)
Krzysztof W. Pankiewicz (Pharmasset, Inc., Tucker,
GA, USA)
Patrick Perlmutter (Monash Univ., PO Box 23, Victoria,
3800, Australia)
Ronald James Quinn (AstraZeneca Nathan, Australia)
Patricia H. Reggio (Kennesaw State University, Kennesaw,
GA, USA)
Juan B. Rodriguez (Universidad de Buenos Aires, Buenos
Aires, Argentina)
David P. Rotella (Lexicon Pharmaceuticals, Princeton,
NJ, USA)
Basil Roufogalis (University of Sydney, Sydney, Australia)
Wendy Sanderson (Johnson & Johnson Pharmaceutical
R& D, Beerse, Belgium)
Graeme Semple (Arena Pharmaceuticals, San Diego, CA,
USA)
Patrick M. Sexton (The University of Melbourne, Melbourne,
Australia)
Yuntao Song (Pfizer Global Research & Development,
MI, USA)
Kumiko Takeuchi (Eli Lilly and Company, Indianapolis,
IN, USA)
Shinji Terao (Shinsenri Minamimachi, Osaka, Japan)
Samuel Toba (Signature Bioscience, San Francisco, CA,
USA)
Istvan Toth (The University of Queensland, Queensland,
Australia)
David J. Triggle (University at Buffalo, Buffalo, NY,
USA )
B.K. Trivedi (Pfizer Global Research & Development,
MI, USA)
Susan Shwu-Chen Tsay (Well-being Biochemical Corp.,
Taiwan)
Sonja Visentin (Università di Torino, Turin,
Italy) |